Value proposition

Transforming patient care through imaging AI

Transforming patient care through imaging AI.

Founded in 2011, icometrix (Leuven, Belgium; Boston, USA) strives for data-driven insights and personalized patient care, supported by artificial intelligence. icometrix offers a portfolio of AI solutions to assist healthcare with various challenges; icobrain extracts data from brain MRI and CT scans for the radiological reporting and clinical management of neurological disorders such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimer's disease. icompanion, a digital platform, and the mobile app helps people with MS and their care team to monitor clinical symptoms and treatments efficiently and objectively. icolung addresses the COVID-19 pandemic by measuring lung involvement on chest CT.

Today, icometrix is internationally active and integrated into more than 300 clinical practices. In addition, icometrix collaborates with healthcare providers and pharmaceutical companies on the evaluation of drug research for neurological disorders.

Multiple Sclerosis, clinical trial imaging, imaging biomarkers, quantitative imaging, advanced imaging, Alzheimer's disease, Epilepsy, Stroke, Traumatic Brain Injury, brain MRI biomarkers, MRI, CT, AI, volumetrics, dementia, neuroradiology, radiology, neurology, and brain